Introduction {#sec1-1}
============

Rat brain neurons are highly sensitive to ischemia; neuronal apoptosis occurs in the early stages of cerebral ischemia, with the reduction in neuronal number and neurotransmitter levels affecting learning and memory\[[@ref1][@ref2][@ref3]\]. Preliminary studies from our research group demonstrated that hypoxia damages rat cerebral cortical neurons, and induces apoptosis\[[@ref4][@ref5]\], indicating that neuronal damage is an important pathological contributor to hypoxic-ischemic encephalopathy.

Neurons and glial cells comprise a unified organism in the central nervous system. Microglia account for 5--20% of total glial cells and play an important role in the regulation of neuronal function and in the maintenance of the microenvironment. Microglia are the first cells to be injured following a central nervous system insult. Cerebral ischemia induces excess activation of microglia, a complex reaction involving intracellular and extracellular ion imbalance, neurotransmitter disorders, and expression of a variety of soluble inflammatory cytokines\[[@ref6][@ref7][@ref8][@ref9][@ref10][@ref11]\]. These manifestations have a unique temporal and spatial pattern, accompanied by changes at the molecular level\[[@ref6][@ref7][@ref8][@ref9][@ref10][@ref11]\]. Early hypoxia can induce microglial proliferation and the activated microglia release free radicals, inflammatory cytokines, superoxide (O~2~^−^) and proinflammatory substances such as tumor necrosis factor-α (TNF-α) and inducible nitric oxide synthase. These factors promote neuronal injury and apoptosis, and aggravate ischemic stroke; in addition, hypoxia leads to changes in microglial mitochondrial structure and function\[[@ref11][@ref12][@ref13][@ref14][@ref15][@ref16]\].

Liu et al.\[[@ref17][@ref18][@ref19][@ref20][@ref21]\] found that neurons in different brain regions exhibited different responses to hypoxia-ischemia, and microglial cell morphology varied significantly. We propose that the extent of microglial activation correlates with neuronal damage, and that activated microglia and apoptotic neurons are mainly localized to the peri-infarct zone. Indeed, similar responses are seen in cerebral ischemia-induced microglial activation that occurs before neuronal apoptosis\[[@ref17][@ref18][@ref19][@ref20][@ref21]\]. The involvement of microglia in ischemic neuronal apoptosis can be observed through changes in expression time and distribution. Activated microglia-mediated inflammation promotes neuronal damage under cerebral hypoxic-ischemic conditions, so it is likely that inhibiting hypoxia-induced activation of microglia will alleviate neuronal damage.

Ginsenoside Rb1 has anti-aging, anti-oxidative and anti-apoptotic properties in neurons, and restores and promotes neuronal regeneration\[[@ref22][@ref23][@ref24][@ref25][@ref26][@ref27][@ref28]\]. Preliminary studies from our research group showed that ginsenoside Rb1 alleviated apoptosis in rat hippocampal neurons and inhibited TNF-α, nitric oxide (NO) and O~2~^−^ expression in activated microglia\[[@ref29][@ref30]\]. However, it remains unclear whether ginsenoside Rb1 reduces neuronal apoptosis by downregulating the activated microglia-mediated inflammatory response. In the present study, we observed the changes in cortical neuronal morphology, cell cycle, and caspase-3 production, as well as TNF-α, NO and O~2~^−^ levels in different culture systems in the presence of ginsenoside Rb1, in an effort to explore the effect and mechanism of ginsenoside Rb1 on cerebral cortical neuronal damage mediated by activated microglia.

Results {#sec1-2}
=======

Effect of ginsenoside Rb1 on the apoptosis of cortical neurons mediated by activated N9 microglia {#sec2-1}
-------------------------------------------------------------------------------------------------

### Cell morphology {#sec3-1}

Under an inverted microscope, the cultured neurons in group A (normal neurons) and group B (neurons co-cultured in medium from microglia treated with ginsenoside Rb1) showed an even distribution and orderly arrangement, with rounded cell bodies, strong refraction, and unfolded cell processes linked into a network. The cultured neurons in groups C (neurons co-cultured in medium from microglia exposed to hypoxia) and E (neurons exposed to hypoxia and treated with ginsenoside Rb1) were distributed evenly but in a less orderly arrangement, and some cells exhibited deformation, large vacuoles, and distorted processes. In groups D (neurons exposed to hypoxia), G (pre-hypoxic neurons co-cultured in medium from microglia exposed to hypoxia and treated with ginsenoside Rb1) and H (pre-hypoxic neurons co-cultured in medium from microglia exposed to hypoxia and treated with ginsenoside-Rb1), the majority of cells were deformed and randomly arranged; projections were deformed and broken with some fragments or residues of apoptotic cells visible. In group F (pre-hypoxic neurons co-cultured in medium from microglia exposed to hypoxia), the number of cells was reduced, the residual cells were deformed, the processes were fractured or even absent, and some fragmented or residual apoptotic cells were visible. Ginsenoside Rb1 had no impact on the morphology of neurons in normal culture medium or in a co-culture system, but led to apparent changes in the morphology of neurons in single or co-culture hypoxic conditions. The extent of morphological changes was in the order group C \< group D \< group F, which suggests that ginsenoside Rb1 exerts a protective effect against hypoxia ([Figure 1](#F1){ref-type="fig"}).

![Effect of ginsenoside Rb1 on the morphology of cerebral cortical neurons after hypoxia (inverted microscope, scale bars: A, B: × 40; C--E, H: × 200; F, G: × 400).\
A (normal neurons) and B (neurons co-cultured in medium from microglia treated with ginsenoside Rb1): The majority of the cells showed even distribution, orderly arrangement, rounded cell bodies, strong refraction, and unfolded cell processes. C (neurons co-cultured in medium from microglia exposed to hypoxia) and E (neurons exposed to hypoxia and treated with ginsenoside Rb1): Cells were distributed uniformly, but a small number of the cells were deformed, with large vacuoles and distorted processes. D (neurons exposed to hypoxia), G (pre-hypoxic neurons co-cul-tured in medium from microglia exposed to hypoxia and treated with ginsenoside Rb1), and H (pre-hypoxic neurons co-cultured in medium from microglia exposed to hypoxia and treated with ginsenoside-Rb1): The majority of cells were scattered randomly and appeared deformed, with fractured processes; some cell debris was visible. F (pre-hypoxic neurons co-cultured in medium from microglia exposed to hypoxia): The number of cultured cells was significantly lower than in the control group, the residual cells appearing deformed, with fractured or absent processes, and a large amount of debris present from dead cells.](NRR-9-252-g001){#F1}

### Cell cycle and apoptosis {#sec3-2}

Flow cytometry results showed that normal neurons were not apoptotic after being cultured with N9 microglia culture medium and ginsenoside Rb1. Ginsenoside Rb1 reduced the apoptosis peak of pre-hypoxic neurons, indicating that the compound has anti-apoptotic effects. The medium harvested after N9 microglial activation could induce the apoptosis of pre-hypoxic or normal neurons. After microglia were activated by hypoxia, the resulting culture medium contained active substances which aggravated neuronal apoptosis, while ginsenoside Rb1 attenuated neuronal apoptosis and exhibited a protective effect before co-culture. Activated microglia-mediated damage of cerebral cortex neurons in Sprague-Dawley rats also affected the neuronal cell cycle, and those neurons cultured in the Rb1-free medium presented no features of the cell cycle. This evidence suggests that ginsenoside Rb1 can enhance the stability of the neuronal cell cycle and alleviate hypoxic injury ([Figure 2](#F2){ref-type="fig"}).

![Effect of ginsenoside Rb1 on the cell cycle and apoptosis of cerebral cortical neurons (flow cytometry).\
A, B (Group A: normal neurons; group B: neurons co-cultured in medium from microglia treated with ginsenoside Rb1). Essentially normal cell cycle: no apparent apoptotic peak, G~2~/M phase twice as high as G~0~--G~1~ phase, and S phase between G~2~/M and G~0~/G~1~. D, E (Group D: neurons ex-posed to hypoxia; group E: neurons exposed to hypoxia and treated with ginsenoside Rb1). After ginsenoside Rb1 was added to the culture system, the apoptotic peak was significantly reduced. C, F--H (Group C: neurons co-cultured in medium from microglia exposed to hypoxia; group F: pre-hypoxic neurons co-cultured in medium from microglia exposed to hypoxia; group G: pre-hypoxic neurons co-cultured in medium from mi-croglia exposed to hypoxia and treated with ginsenoside Rb1; Group H: pre-hypoxic neurons co-cultured in medium from microglia exposed to hypoxia and treated with ginsenoside-Rb1). An apoptotic peak was found in each group. In groups F--H, different levels of cell cycle distortion can be observed, the mildest in group G and most severe in group F, where no boundary between G2/M phase and G~0~--G~1~ phase was found, and no mul-tiple proportion existed. APO: Apoptotic peak.](NRR-9-252-g002){#F2}

### Caspase-3 expression in neurons {#sec3-3}

Western blot analysis showed that ginsenoside Rb1 had no impact on caspase-3 expression in the neurons in a normal co-culture system (*P* \> 0.05); hypoxia-activated N9 microglia medium upregulated caspase-3 expression in normally cultured neurons (*P* \< 0.05), while ginsenoside Rb1 downregulated caspase-3 expression in hypoxia-induced neurons (*P* \< 0.05). Hypoxia-activated N9 microglial medium elevated caspase-3 expression in neurons (*P* \< 0.05), while ginsenoside Rb1 inhibited the effect of hypoxia on caspase-3 expression (*P* \< 0.05; [Figure 3](#F3){ref-type="fig"}).

![Effect of ginsenoside Rb1 on caspase-3 expression in hypoxic cerebral cortical neurons.\
Data are expressed as mean ± SD. Comparisons between groups were tested by one-way analysis of variance, and pairwise comparisons were per-formed using the least significant difference test. ^a^*P* \< 0.05, *vs.* group C; ^b^*P* \< 0.05, *vs.* group D; ^c^*P* \< 0.05, *vs*. group F; ^d^*P* \< 0.05, *vs.* group G. Group A: Normal neurons. Group B: Neurons co-cultured in medium from microglia treated with ginsenoside Rb1. Group C: Neurons co-cultured in medium from microglia exposed to hypoxia. Group D: Neurons exposed to hypoxia. Group E: Neurons exposed to hypoxia and treated with ginse-noside Rb1. Group F: Pre-hypoxic neurons co-cultured in medium from microglia exposed to hypoxia. Group G: Pre-hypoxic neurons co-cultured in medium from microglia exposed to hypoxia and treated with ginsenoside Rb1. Group H: Pre-hypoxic neurons co-cultured in medium from microglia exposed to hypoxia and treated with ginsenoside-Rb1.](NRR-9-252-g003){#F3}

Effect of ginsenoside Rb1 on the expression of inflammatory cytokines (TNF-α, NO, O~2~^−^) secreted from hypoxia-activated N9 microglia {#sec2-2}
---------------------------------------------------------------------------------------------------------------------------------------

Using an ELISA assay, we detected that TNF-α expression was very poorly expressed in the culture systems without N9 microglial cells (groups A, D, E), and there was no significant difference among these three groups (*P* \> 0.05). This evidence indicates that ginsenoside Rb1 has no impact on TNF-α expression in normally cultured cortical neurons. Compared with normal neurons cultured in hypoxia-activated N9 microglia culture medium (group C), low levels of TNF-α expression were found in normal neurons cultured in normal N9 microglial activation medium (group B) (*P* \< 0.05). Compared with hypoxic neurons cultured in hypoxia-activated N9 microglial medium (group F), TNF-α expression was reduced after ginsenoside Rb1 was added to the culture medium in groups G and H (*P* \< 0.05). Furthermore, group G was lower than group H (*P* \< 0.05), suggesting that ginsenoside Rb1 suppressed the production of TNF-α in the co-culture system, and in particular in hypoxia-activated N9 microglia ([Figure 4A](#F4){ref-type="fig"}).

![Effect of ginsenoside Rb1 on the expression of inflammatory mediators (TNF-α, NO, O~2~^−^) secreted from hypoxia-activated N9 microglia.\
Data are expressed as mean ± SD. Comparisons between groups were tested by one-way analysis of variance, and pairwise comparisons were per-formed using the least significant difference test. ^a^*P* \< 0.05, *vs*. group A; ^b^*P* \< 0.05, *vs.* group B; ^c^*P* \< 0.05, *vs.* group C; ^d^*P* \< 0.05, *vs*. group F; ^e^*P* \< 0.05, *vs*. group G. Group A: Normal neurons. Group B: Neurons co-cultured in medium from microglia treated with ginsenoside Rb1. Group C: Neurons co-cultured in medium from microglia exposed to hypoxia. Group D: Neurons exposed to hypoxia. Group E: Neurons exposed to hypoxia and treat-ed with ginsenoside Rb1. Group F: Pre-hypoxic neurons co-cultured in medium from microglia exposed to hypoxia. Group G: Pre-hypoxic neurons co-cultured in medium from microglia exposed to hypoxia and treated with ginsenoside Rb1. Group H: Pre-hypoxic neurons co-cultured in medi-um from microglia exposed to hypoxia and treated with ginsenoside-Rb1. TNF-α: Tumor necrosis factor-α; NO: nitric oxide; O~2~^−^: superoxide.](NRR-9-252-g004){#F4}

Production of NO and O~2~^−^ was determined using Griess reagent and the water-soluble tetrazolium assay, respectively. The results showed that a hypoxic environment in any of the culture systems significantly increased NO or O~2~^−^ production in cells, and microglial cells were more sensitive than neurons (*P* \< 0.05). Ginsenoside Rb1 inhibited NO or O~2~^−^ production in the hypoxia-induced cells, mainly N9 microglial cells (Figure [4B](#F4){ref-type="fig"}, [C](#F4){ref-type="fig"}).

Discussion {#sec1-3}
==========

After cerebral ischemia or brain damage, microglia move rapidly from a resting state to a state of activation. These cells begin to proliferate, migrate and differentiate, release cytotoxins and inflammatory mediators, secrete cytokines, and upregulate immune expression. A series of previous studies showed that activated microglia *in vitro* released a large number of free radicals and inflammatory cytokines, which activated or aggravated neuronal damage; conversely, neuronal damage activated microglial cells, thus leading to a pathological cascade and aggravating the damage induced by ischemia\[[@ref31][@ref32][@ref33][@ref34][@ref35][@ref36][@ref37][@ref38][@ref39]\].

Previous preliminary studies from our research group showed that: (1) Hypoxia can induce microglial activation, increasing the expression of secreted neurotoxic cytokines; hypoxia also causes neuronal damage or apoptosis, and increases caspase-3 production; microglial activation is consistent with neuronal apoptosis in time distribution and extent, suggesting that stress-induced microglial activation is closely linked with neuronal apoptosis. (2) After 12 hours of hypoxia, microglial medium alone can inhibit the growth and proliferation of normally cultured cortical neurons in Sprague-Dawley rats, and trigger neuronal apoptosis, while the co-culture with hypoxia medium aggravates the decline of neuronal viability and apoptosis. (3) In a co-culture system containing hypoxic microglia, the production of NO, O~2~^−^, and TNF-α was higher than that in normal microglial single- or co-culture, and normal hypoxic neuronal culture systems. This evidence indicates that the high level of neurotoxins produced by microglia is an important factor in hypoxic neuronal damage\[[@ref5][@ref9][@ref10]\]. From these preliminary results, we hypothesized that neuronal damage can be alleviated by regulating hypoxia-activated microglia. Therefore, in the present study, we added ginsenoside Rb1 to microglia and cortical neurons in a co-culture system in an effort to explore the role of, and mechanism underlying, cerebral cortical neuronal injury mediated by hypoxia-activated microglia.

Ginsenoside Rb1 is a class of ginseng monomer\[[@ref22][@ref23][@ref29][@ref30]\]. Previous studies have found that ginsenoside Rb1/Rg1 can alleviate impairments in learning and memory, and regulate the cholinergic system in a variety of experimental animal models. In addition, ginsenoside Rb1/Rg1 exerts a protective effect on dopamine neurons by reducing the stress response induced by 1-methyl-4-phenyl 2,3,6-tetrahydropyridine/1-methyl-4-phenyl pyridine, and also alleviates tau hyperphosphorylation through regulation of the activities of glycogen synthase kinase 3β and protein phosphatase 2A\[[@ref40][@ref41][@ref42][@ref43][@ref44][@ref45][@ref46][@ref47][@ref48]\]. The present study demonstrates the protective effect of ginsenoside Rb1 on the damage to cerebral cortical neurons in rats mediated by hypoxia-activated microglia. The main findings are summarized as follows: (1) Ginsenoside Rb1 protects against neuronal morphology damage and structure in single- and co-culture hypoxic systems. (2) Ginsenoside Rb1 alleviates neuronal apoptosis in alone hypoxia system and hypoxia co-culture system, and its protective effect appears before the neurons are placed in co-culture. (3) Ginsenoside Rb1 enhances the stability of the neuronal cell cycle and alleviates hypoxic injury. (4) Ginsenoside Rb1 reduces caspase-3 production of neurons in single- and co-culture hypoxic systems, and its inhibition effect appears before the co-culture. (5) Ginsenoside Rb1 inhibits the production of TNF-α, NO, and O~2~^−^ in a hypoxia-activated N9 microglial co-culture system. Together, these results indicate that by downregulating the expression of TNF-α, NO, O~2~^−^ and other inflammatory mediators in hypoxia-activated microglia, ginsenoside Rb1 regulates inflammation and attenuates neuronal injury.

In summary, the present study is the first to demonstrate that ginsenoside Rb1 protects rat cerebral cortical neurons against hypoxia-activated microglia-mediated injury, and that the associated mechanism is mediated by the downregulation of NO, O~2~^−^, and TNF-α in hypoxia-activated microglia. The present results suggest that ginsenoside Rb1 is a promising candidate for clinical use in the prevention of neuronal degeneration following cerebral ischemia.

Materials and Methods {#sec1-4}
=====================

Design {#sec2-3}
------

A comparative cytological observation.

Time and setting {#sec2-4}
----------------

Experiments were performed in July 2012 at the Neurobiology Research Center of Fujian Medical University, China.

Materials {#sec2-5}
---------

### Cells {#sec3-4}

N9 mouse microglial cell lines were provided by the U.S. National Cancer Institute.

### Animals {#sec3-5}

Twenty pregnant, clean-grade Sprague-Dawley rats at 19 days of gestation were purchased from the Experimental Animal Center of Fujian Medical University, China (license No. SCXK (Min) 2012-0001).

### Drugs {#sec3-6}

Ginsenoside Rb1 is one of the main active ingredients of ginseng, and also the glycoside derived from protopanaxadiol. It is extracted from the stem, basal part of stem, root, and alabastrum root of *Panax ginseng* C.A. Meyer. The chemical formula is C~54~H~92~O~23~ ([Figure 5](#F5){ref-type="fig"})\[[@ref49]\] and its molecular weight is 1,109.29. Ginsenoside Rb1 was obtained at \> 98% purity from the Department of Organic Chemistry, Jilin University, China. According to previous reports of ginsenoside Rb1 in nerve cells\[[@ref22][@ref23][@ref29][@ref30]\], we selected 100 μg/mL as the drug concentration and 6 hours as the administration time.

![Chemical structure of ginsenoside Rb1.](NRR-9-252-g005){#F5}

Methods {#sec2-6}
-------

### Culture of microglia {#sec3-7}

N9 microglial cell lines cryopreserved in liquid nitrogen were regarded as passage 2 cells, which were then seeded at 4 × 10^5^ /mL in cell culture flasks at 37°C and 5% CO~2~. After 3 days, the adherent cells covered 50--60% of the bottom of the culture flask and were trypsinized using 0.02% EDTA. Then cells were passaged at 1:3 and cultured in another flask, and cultured cells at passages 3--8 were selected for experiments. The culture medium was composed of 89% high-glucose Dulbecco\'s modified Eagle medium (DMEM) + 10% fetal bovine serum + 1% penicillin-streptomycin.

### Immunofluorescence identification of microglia {#sec3-8}

Mononuclear cell membrane adhesion molecule III complement receptor CD11b served as a specific microglial marker\[[@ref50][@ref51][@ref52]\]. After the cells were stabilized for 24 hours, they were stained and identified. The culture medium was discarded and fixed with 4% paraformaldehyde at room temperature for 30 minutes, then treated with 0.3% Triton X-100 for 20 minutes, and incubated with 3% H~2~O~2~ at room temperature for 10 minutes to eliminate endogenous peroxidase activity. Between the steps, cells were rinsed with 0.01 mol/L PBS (pH 7.4). The washed cells were then incubated with blocking solution (PBS containing 5% bovine serum albumin + 0.1% Triton X-100) for 30 minutes at room temperature to block nonspecific background staining. Subsequently, the blocking solution was discarded and the cells were incubated with rabbit anti-CD11b polyclonal antibody (1:1,000; Chemicon, Santa Cruz, CA, USA) at 37°C for 1 hour and then overnight at 4°C. After washing three times in PBS, 5 minutes each time, the cells were further incubated with rhodamine-labeled goat anti-rabbit IgG (1:200; Chemicon) at 37°C for an additional 1 hour. After a final PBS wash, the cells were mounted using phosphoglycerol and observed under a fluorescent microscope (Leica, Solms, Germany). The negative control was incubated with 0.01 mol/L PBS instead of primary antibody. Thirty fields of view were photographed at 200 × magnification and randomly selected for counting the percentage of positive cells under a phase contrast microscope (Nikon, Tokyo, Japan). Images were analyzed using an image analysis system (Bio-Rad, Hercules, CA, USA). Images containing 95% microglia were included in the study.

### Establishment of a hypoxic microglial culture system {#sec3-9}

To establish the hypoxic culture system, the microglial cells were resuspended and the cell density was adjusted accordingly. The hypoxic microglial culture system was established at 37°C in 94% N~2~, 1% O~2~ and 5% CO~2~, followed by 12 hours hypoxia. Hypoxia-induced activation of microglia was defined based on microglial function (proliferation activity, expression of neurotoxic factors such as TNF-α, NO, O~2~^−^, and mitochondrial structure)\[[@ref9][@ref10][@ref53]\]. The resulting medium provided conditioned culture medium (50% of microglia culture fluid + 50% of neuronal culture fluid) for the subsequent establishment of co-culture medium.

### Harvesting, purification and culture of rat cerebral cortical neurons {#sec3-10}

Rats at 19 days of gestation were anesthetized, the uterus was dissected out, and fetal brain was harvested, ground, filtered, resuspended, and centrifuged. After the supernatant was discarded, the cells were triturated and inoculated in high-glucose DMEM containing 10% fetal bovine serum, 1% L-glutamine, 1% MEM vitamins, 0.1 IU/L penicillin G, 0.1 IU/L streptomycin, 2 g/L NaHCO~3~) at 37°C and 5% CO~2~. The cells were purified and cultured in Neurobasal-A Medium (Life Technologies, Gaithersburg, MD, USA) containing 2% B-27 additive, 1% fetal bovine serum, 1% cytosine arabinoside, 0.2% L-glutamine, 0.1% kynurenic acid stock solution, 0.1% fluorodeoxyuridine stock solution, 0.175% β-mercaptoethanol stock solution, 50 U/mL penicillin G, and 50 U/mL streptomycin. On day 7, cells were collected for identification\[[@ref54][@ref55]\].

### Identification of cortical neurons using immunofluorescence staining {#sec3-11}

The neuron-specific microtubule-associated protein 2 was used to identify neurons\[[@ref56][@ref57]\]. Briefly, after the culture medium was discarded, the cells were fixed in cold 4% paraformaldehyde for 30 minutes, treated with 0.3% Triton X-100 for 20 minutes, and then incubated with 30 μL of 0.3% H~2~O~2~/methanol solution at room temperature for 10 minutes, 30 μL of normal goat serum at room temperature for 10 minutes, 50 μL of mouse anti-microtubule-associated protein 2 polyclonal antibody (1:1,000; Chemicon) at 4°C overnight, and FITC-labeled sheep anti-mouse IgG (1:100; Chemicon) at 37°C for 1 hour. Between the incubation steps, cells were rinsed with PBS. Finally, the slices were mounted with phosphoglycerol\[[@ref54][@ref55][@ref56]\] and observed with fluorescence microscopy. The negative control was incubated with 0.01 mol/L PBS instead of primary antibody. Thirty fields of view at 200 × magnification were randomly selected for counting the percentage of positive cells under a phase contrast microscope (Nikon). The images were then analyzed using an image analysis system (Bio-Rad) and those containing 90% microglia were included in the study.

### Establishment of cortical neuron hypoxia culture system {#sec3-12}

To establish culture system, cortical neurons were resuspended according to the requirements of different experimental methods, and the cell density was adjusted. The hypoxic culture system was established at 37°C in 94% N~2~, 1% O~2~ and 5% CO~2~, followed by 12 hours of hypoxia. The hypoxia-induced activation of cortical neurons was defined based on biological function (proliferation activity, expression of neurotoxic factors such as TNF-α, NO, O~2~^−^, and mitochondrial structure)\[[@ref9][@ref10][@ref53]\]. This also provided the conditioned culture medium (50% of microglia culture fluid + 50% of neuronal culture fluid) for the subsequent establishment of co-culture medium.

### Establishment of microglial and cortical neuronal co-culture system {#sec3-13}

Rat cortical neurons were primarily cultured in conditioned medium in which the microglia were previously cultured, to establish the co-culture system. The co-culture (or co-hypoxia) time was 12 hours.

### Cell grouping {#sec3-14}

Group A: Normal neurons. Group B: Normal neurons co-cultured in medium from microglia treated with ginsenoside Rb1; normal N9 microglia were treated with ginsenoside Rb1 for 6 hours, then 3 mL culture medium was harvested and co-cultured with normal neurons for 12 hours. Group C: Normal neurons co-cultured in medium from microglia exposed to hypoxia; after microglia were subjected to hypoxia for 12 hours, 3 mL culture medium was harvested and co-cultured with normal neurons for 12 hours. Group D: Hypoxia-exposed neurons; neurons were subjected to hypoxia for 12 hours. Group E: Hypoxia-exposed neurons treated with ginsenoside Rb1; neurons were subjected to hypoxia for 12 hours and then treated with ginsenoside Rb1 for 6 hours. Group F: Pre-hypoxic neurons co-cultured in medium from microglia exposed to hypoxia; after microglia were subjected to hypoxia for 12 hours, 3 mL culture medium was harvested and co-cultured with pre-hypoxic neurons for an additional 12 hours. Group G: Pre-hypoxic neurons co-cultured in medium from microglia exposed to hypoxia and treated with ginsenoside Rb1; after neurons were subjected to hypoxia for 12 hours and ginsenoside Rb1 was applied for 6 hours, 3 mL culture medium was harvested and co-cultured with pre-hypoxic neurons for an additional 12 hours. Group H: Pre-hypoxic neurons co-cultured in medium from microglia exposed to hypoxia and treated with ginsenoside-Rb1; after microglia were exposed to hypoxia for 12 hours, 3 mL culture medium was harvested and co-cultured with pre-hypoxic neurons for an additional 12 hours, followed by application of ginsenoside Rb1 for 6 hours. Cells in each group were cultured in 6-well plates (Corning, Michigan, USA) with 3 × 10^6^ cells per well.

The growth and distribution of neurons were observed under an inverted microscope. The single cell suspension in each group was prepared, centrifuged, washed, fixed, filtrated, and stained with propidium iodide (Beyotime Institute of Biotechnology, Shanghai, China). The proliferation cycle and apoptosis of neurons were determined using a flow cytometer (BD Company, Franklin Lakes, NJ, USA). Neuronal caspase-3 expression was determined with western blot analysis. Briefly, the protein sample was extracted from the lysed cells, loaded onto the gel, electrophoresed, and proteins transferred onto a polyvinylidene fluoride membrane, which was then rinsed and blocked to prevent nonspecific binding. The membrane was incubated with mouse anti-rat caspase-3 monoclonal antibody (1:500; Beyotime Institute of Biotechnology) at 4°C overnight, and then with goat anti-mouse IgG (1:100; Beyotime Institute of Biotechnology) at 37°C for 90 minutes. Electrochemiluminescence was used to visualize the proteins with absorbance at 405 nm detected using a UV spectrophotometer (Beckman Company, Kraemer Boulevard Brea, CA, USA). The experiment was repeated four times. The ratio of caspase-3 to β-actin absorbance was used to represent caspase-3 expression level.

### Detection of the production of neurotoxic factors in culture medium {#sec3-15}

The expression of TNF-α in culture medium was detected using an ELISA kit (R & D Systems Inc., Minneapolis, MN, USA) according to the manufacturer\'s instructions. Absorbance at 450 nm was determined using a UV spectrophotometer (Beckman) and the concentration of samples (pg/mL) was calculated from a standard curve.

The expression of NO in the culture medium was detected with a Griess reagent assay. Cells were lysed in nitrogen-free lysate, centrifuged, and the supernatant was discarded. NO standards (1--100 mmol/L; Beyotime Institute of Biotechnology) and samples were added to the culture plate (50 mL/well), to which Griess reagents I and II were added. The absorbance at 540 nm was measured with a UV spectrophotometer.

The expression of O~2~^−^ in the culture medium was detected using the water-soluble tetrazolium-1 reduction assay. Briefly, when the cells reached 85% confluence in the 96-well culture plate, the culture medium was discarded, the cells were washed with Dulbecco\'s PBS and incubated with 200 μL/well detection solution (Beyotime Institute of Biotechnology) at 37°C for 5 minutes. There were six parallel wells in each group. The absorbance value at 450 nm was measured with a UV spectrophotometer.

### Statistical analysis {#sec3-16}

Data are expressed as mean ± SD and analyzed using SPSS version 13.0 (SPSS, Chicago, IL, USA). The difference between groups was compared using one-way analysis of variance and further pairwise comparisons were performed using the least significant difference test. *P* \< 0.05 was considered statistically significant.
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